Sort by:

select Language:

Antiretroviral drug chart

NAM; AIDSMAP, (2019)

Version: 14 March 2019; A one-page reference guide to all the anti-HIV drugs licensed for use in the European Union, with information on formulation, dosing, key side-effects and food restrictions. The previous edition of the drugs chart is also available to download in Russian.

Список Противоретровирусных препаратов. HIV drugs chart

East Europe and Central Asia Union of People Living with HIV (ECUO), Eds.: NAM; AIDSMAP, (2018)

Translated and adapted from the original English Antiretroviral drugs chart by the East Europe and Central Asia Union of People Living with HIV (ECUO). This resource shows drugs currently available in the Eastern Europe and Central Asia area. Last update Oct. 2018

Landscape for HIV rapid diagnostic tests for HIV self-testing

World Health Organization WHO; UNITAID, (2018)

This fourth edition of the Unitaid/WHO market and technology landscape: HIV rapid diagnostic tests for self-testing report summarizes the current HIV testing gap; the challenges facing efforts to scale up; and the potential role HIV self-testing (HIVST) could play to achieve the United Nation’s 90-90-90 targets. In particular, the report synthesises the existing and emerging market demand and supply of kits. The information in this report is intended for manufacturers, donors, national programmes, researchers and other global health stakeholders who are exploring the potential role of HIVST.

Guidelines for the diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children. Policy brief

World Health Organization WHO, (2018)

Cryptococcal meningitis is a serious opportunistic infection which is a major cause of morbidity and mortality in people living with HIV with advanced disease, accounting for an estimated 15% of all AIDS-related deaths globally. An estimated 223,100 cases of cryptococcal meningitis result in 181,000 deaths each year among people living with HIV. Cryptococcal disease is rare in children with HIV, even in areas with a high disease burden among adults

Guidelines for the diagnosis, prevention, and management of cryptococcal disease in HIV-infected adults, adolescents and children

World Health Organization (WHO), (2018)

March 2018.Supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection

Key Considerations for Introducing New HIV Point-of-Care Diagnostic Technologies in National Health Systems

United National Children’s Fund (UNICEF), (2018)

This document describes the key areas that national governments should consider for the introduction and scale-up of point-of-care (POC) diagnostics within national programmes, as new innovative POC technologies are being introduced into the market. The next steps taken to include these new innovations within the broader context of national diagnostic networks of conventional laboratories could influence the achievement of the 2030 Fast Track targets for ending the AIDS epidemic.
POC diagnostics, when strategically introduced and integrated into national diagnostic networks, may help catalyse changes that improve the way diagnostics and clinical services are delivered. This document distils this understanding based on programmatic and market experiences of introducing POC diagnostics through catalytic investments in POC HIV technologies across numerous countries in sub-Saharan Africa.

93 hits